Advertisement
News
Advertisement

EyeGate licenses orphan eye disease patents to Avedro

Fri, 10/26/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

EyeGate Pharmaceuticals Inc. is licensing its patents relating to a treatment for an orphan eye disease called keratoconus to its Waltham neighbor Avedro Inc. for an undisclosed sum.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading